Skip to main content
. 2017 Oct-Dec;21(4):e2017.00061. doi: 10.4293/JSLS.2017.00061

Table 3.

Most Recent Match-Pair Analyses of Laparoscopic Versus OLRs for HCC and CRC Mets

Cancer Study n Surgery Cirrhosis (%) P Conversion Rate (%) Blood Loss (mL) P R0 resection (%) Hospital Stay (days) P 5-y Survival
HCC Han et al3 88 LLR 62.5 NS 9.1 500 NS 98.9 NS 8 =0.001 76.4 mo NS
88 OLR 59.1 525 94.3 10 73.2 mo
Kim et al12 29 LLR 100 NS 23 485 NS 89.7 NS 7.7 <0.001 47.9 mo NS
29 OLR 100 262 96.6 13.4 59.5 mo
Cheung et al13 32 LLR 87.5 NS 150 =0.001 97 NS 4 <0.001 76.6 NS
64 OLR 79.7 300 94 7 57
Truant et al14 36 LLR 1001 19.4 452 NS 6.5 =0.003 70 NS
53 OLR 1001 447 9.5 46
Hu et al15 30 LLR 83 0 520 NS 13 <0.01 53.3 NS
30 OLR 480 20 50
Lee et al16 33 LLR 84.8 =0.038 18.2 150 NS 97 NS 5 <0.001 76 NS
50 OLR 64 240 98 7 76,1
CRC metastases Tohme et al4 66 LLR 4 150 NS 88 NS 4 <0.001 51.3 NS
66 OLR 250 89 5 38.6
Guerron et al17 40 LLR 5 376 =0.04 1 cm NS 3.7 <0.001 892 NS
40 OLR 753 1 cm 6.5 812
Qiu et al18 30 LLR 6.7 NS 6.7 215 <0.001 9.9 cm NS 7.5 <0.001
30 OLR 10 385 1 cm 11.5
Cannon et al19 35 LLR 202 <0.001 97 p=0.02 4.8 <0.001 36 NS
138 OLR 392 81 7.8 37
Cheung et al20 20 LLR 0 200 =0.043 0.6 cm NS 4.5 =0.021 69.4 mo NS
40 OLR 300 0.5 cm 7 42.1 mo
Schiffman et al21 242 LLR 262 =0.049 94.5 NS 6.5 =0.007 51.4 NS
386 OLR 385 87.4 8.8 45.9
Fretland et al23 133 LLR 2 300 NS 94 NS 53h <0.001
147 OLR 200 93 96h
1

All F3 and F4 fibrosis;

2

2-year survival; 3references 14–17 included in this meta-analysis. [-] information not provided; mo, months; NS, not significant.